HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody BIWA 4 (bivatuzumab)

humanized monoclonal antibody with an intermediate affinity for CD44v6 for treatment of squamous cell carcinoma of head & neck
Also Known As:
bivatuzumab; BIWA 4 (MAb)
Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Marres, Henri A M: 2 articles (10/2003 - 09/2003)
2. Roos, Jan C: 2 articles (10/2003 - 09/2003)
3. van Dongen, Guus A M S: 2 articles (10/2003 - 09/2003)
4. de Bree, Remco: 2 articles (10/2003 - 09/2003)
5. Börjesson, Pontus K E: 2 articles (10/2003 - 09/2003)
6. Postema, Ernst J: 2 articles (10/2003 - 09/2003)
7. Oyen, Wim J G: 2 articles (10/2003 - 09/2003)
8. Erhardt, Thomas: 1 article (09/2008)
9. Golze, Wolfram: 1 article (09/2008)
10. Hanft, Gertraud: 1 article (09/2008)

Related Diseases

1. Head and Neck Neoplasms (Head and Neck Cancer)
2. Squamous Cell Carcinoma (Epidermoid Carcinoma)
3. Neoplasms (Cancer)
4. Residual Neoplasm
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. monoclonal antibody BIWA 4 (bivatuzumab)

Related Therapies and Procedures

1. Radioimmunotherapy